The termination of crucial federal health insurance subsidies has plunged the United States into a state of uncertainty, leaving millions of Americans facing the imminent threat of losing affordable healthcare coverage. This development has ignited a deeply fragmented and politically polarized
A monumental $50 billion federal initiative designed to rescue America's struggling rural healthcare systems has instead become a flashpoint for intense political and financial conflict across the country. The Trump administration's five-year Rural Health Transformation Program, administered by the
A leading mind in policy and legislation, Donald Gainsborough is at the helm of Government Curated, where he deciphers the complex interplay between Washington and industry. In the wake of the White House’s recent announcement of a landmark deal with major pharmaceutical companies, we sat down with
The delicate balance of healthcare affordability for millions of Americans now hinges on an unusual and high-stakes legislative confrontation brewing within the U.S. House of Representatives. A looming deadline on Affordable Care Act (ACA) subsidies, which help lower insurance premiums, has pushed
The Trump administration has announced a major expansion of its drug pricing initiative by striking deals with nine more pharmaceutical giants, framing the development as a historic victory for American consumers that will turn a bold policy into an industry standard. Administration officials claim
With a career spanning the highest echelons of policy and legislation, Donald Gainsborough, head of Government Curated, offers a rare look inside the complex machinery of U.S. health policy. His insights pull back the curtain on the recent, tumultuous internal debates at the Department of Health
